Capstone Continues to Diversify its Business with Project in West African Village
Apr 10, 2017 12:30 pm UTC| Business
CHATSWORTH, Calif., April 10, 2017 -- Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST), the world's leading clean technology manufacturer of microturbine energy systems, announced today that it...
InterDigital Announces Date for First Quarter 2017 Financial Results
Apr 10, 2017 12:30 pm UTC| Business
WILMINGTON, Del., April 10, 2017 -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that the company will release its first quarter 2017 financial results before...
Cerner to Release First Quarter 2017 Earnings Results April 27
Apr 10, 2017 12:30 pm UTC| Business
KANSAS CITY, Mo., April 10, 2017 -- Cerner Corporation(Nasdaq:CERN) today announced it will release its first quarter 2017 earnings results after the market closes Thursday, April 27. Following the release, the company...
Apr 10, 2017 12:08 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., April 10, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (CBMG or the Company), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies...
Apr 10, 2017 12:08 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., April 10, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (CBMG or the Company), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies...
Apr 10, 2017 12:08 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., April 10, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (CBMG or the Company), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies...
OncoMed Pharmaceuticals Announces Bayer Terminates its Option to License Vantictumab or Ipafricept
Apr 10, 2017 12:08 pm UTC| Business
REDWOOD CITY, Calif., April 10, 2017 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology...